J-TEC’s Cell Sheet for Vitiligo Now in Line for Approval in Japan

February 14, 2023
A Japanese health ministry panel on February 13 gave the thumbs-up to approvals for two regenerative medicine products including Japan Tissue Engineering’s (J-TEC) autologous cultured epidermal cell sheet containing melanocytes for the treatment of stable vitiligo. The J-TEC product was...read more